Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

AGM Statement

23 Mar 2016 11:38

RNS Number : 0436T
Premier Veterinary Group PLC
23 March 2016
 

 

 

 

 

PREMIER VETERINARY GROUP plc

("PVG" or "the Company")

 

 

CONTINUED GROWTH IN PET CARE PLAN

 

 

London, UK, 23 March 2016 - At today's Annual General Meeting, Premier Veterinary Group plc (LSE: PVG) reports on progress made during the second quarter in the growth in the number of fee generating pet care plans provided by third party veterinary clinics under its preventative healthcare programme for pets branded "Pet Care Plan" ("PCP"):

 

Pet Care Plan Customer Growth

 

The number of pets on active plans in the second quarter of 2016, and in the preceding two quarters, are as follows:

 

As at

September 2015

As at

December 2015

As at

March 2016

Rest of World

3,000

5,000

10,000

United Kingdom

79,000

99,000

107,000

Total no of pets on plan

82,000

104,000

117,000

 

100th Veterinary Clinic Signed Up to PCP in The Netherlands

The Company also announces that it has entered into contractual arrangements for its Pet Care Plan ("PCP") with over 100 veterinary clinic customers in the Netherlands. PCP now covers 8,000 pets in the Netherlands where the plan is sold under the name of Huisdieren ZorgPlan ("HZP"). There are approximately 1,000 domestic animal veterinary practices in the Netherlands and this market has similar compliance rates on vaccination and flea, worm and tick control to the UK. The Company's Dutch customer practices have embraced HZP to improve client loyalty, increase revenue, improve cash flow and differentiate themselves in a very competitive market.

 

Iain Ross, Chairman of PVG, commented:

 

"The disposal of our veterinary business at the end of 2015 has enabled our management to focus on the development and expansion of PCP, and the board is greatly encouraged by the consistent growth in the number of pets on plan.

"Integral to our strategy is to grow more aggressively in overseas territories. The Netherlands was among the first countries targeted for overseas expansion for PCP, and our business there has shown rapid growth to date.

 

"The board remains confident of further good progress both this year and beyond."

 

 

For further information, please contact:

 

Premier Veterinary Group plc Tel: +44 (0)117 970 4130

Dominic Tonner, Chief Executive Officer

Daniel Smith, Chief Financial Officer

 

Square1 Consulting Tel: +44 (0)207 929 5599

David Bick/Brian Alexander

 

 

Note to Editors:

 

PVG's services to third party veterinary practices include the administration of a preventative healthcare program for pets branded "Pet Care Plan" and the operation of a buying group (the "PVA Buying Group") which offers enhanced discounts to member practices.

 

Pet Care Plan is a structured, preventative healthcare program for cats, dogs and rabbits and is available through veterinary practices. The program is seen as a way of providing gold standard care for pets at an affordable price for the client, by way of fixed monthly payments.

 

Pet Care Plan uses a clinical approach to prevention, as this is the most effective method of ensuring illnesses are diagnosed more quickly and not given a chance to advance. What truly sets Pet Care Plan apart is its unique approach of offering an end-to-end solution which has been proven to work. PVA works alongside practices to create a tailor-made, cost-effective service for clients, one that delivers excellent care to their patients and significantly improves practice performance.  

 

The PVA Buying Group, is now the UK's largest veterinary buying group without group interests in veterinary practices or veterinary wholesalers.

 

For further details: http://www.premiervetalliance.co.uk/

 

 

This announcement includes "forward-looking statements" which include all statements other than statements of historical facts, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations, and any statements preceded by, followed by or that include forward-looking terminology such as the words "targets", "believes", "estimates", "expects", "aims", "intends", "will", "can", "may", "anticipates", "would", "should", "could" or similar expressions or the negative thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the Company's control that could cause the actual results, performance or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this announcement to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. As a result of these factors, readers are cautioned not to rely on any forward-looking statement.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMUOOARNBAOUAR
Date   Source Headline
8th Jun 20078:00 amRNSBlocklisting Interim Review
8th Jun 20078:00 amRNSBlocklisting Interim Review
7th Jun 20077:00 amRNSKerraped Launch
31st May 200710:13 amRNSVoting Rights and Capital
31st May 20077:02 amRNSResearch Update
22nd May 20077:01 amRNSTrinam Update
2nd May 20077:01 amRNSTrinam(R) RAC Application
30th Apr 20074:10 pmRNSVoting Rights and Capital
27th Apr 20077:01 amRNSRegulatory Update
26th Apr 20075:29 pmRNSResult of AGM
24th Apr 20077:01 amRNSResearch Update
2nd Apr 20071:42 pmRNSVoting Rights and Capital
2nd Apr 200712:22 pmRNSAnnual Information Update
30th Mar 20071:57 pmRNSHolding(s) in Company
19th Mar 20072:20 pmRNSBlock Listing Application
15th Mar 20075:37 pmRNSHolding(s) in Company
12th Mar 20072:12 pmRNSHolding(s) in Company
7th Mar 20077:01 amRNSFinal Results
5th Mar 20075:33 pmRNSHolding(s) in Company
1st Mar 200710:40 amRNSVoting Rights and Capital
23rd Feb 20079:00 amRNSHolding(s) in Company
22nd Feb 20077:01 amRNSStroke Patent
16th Feb 20079:00 amRNSHolding(s) in Company
16th Feb 20077:00 amRNSResearch Update
6th Feb 20071:03 pmRNSHolding(s) in Company
5th Feb 20072:41 pmRNSOption Awards
1st Feb 20077:01 amRNSEuropean Grant Awarded
25th Jan 20075:19 pmRNSHolding(s) in Company
22nd Jan 200711:24 amRNSTotal Voting Rights
19th Jan 200712:28 pmRNSNotice of Results
15th Jan 200712:45 pmRNSRe: Award
11th Jan 20077:01 amRNSResearch Update
5th Jan 20077:53 amRNSResearch Update
20th Dec 20062:00 pmRNSHolding(s) in Company
20th Dec 200610:28 amRNSVoting and Rights Capital
18th Dec 20067:01 amRNSHolding(s) in Company
14th Dec 20067:01 amRNSPlacing of Shares
4th Dec 200611:26 amRNSBlocklisting Interim Review
4th Dec 200611:21 amRNSBlocklisting Interim Review
27th Nov 20061:44 pmRNSHolding(s) in Company
13th Oct 20067:00 amRNSCerepro Patent Granted
10th Oct 20067:01 amRNSRe: Kerraboot
2nd Oct 20063:49 pmRNSHolding(s) in Company
27th Sep 20067:01 amRNSResearch Update
8th Sep 20064:11 pmRNSHolding(s) in Company
5th Sep 20067:03 amRNSResearch Update
1st Sep 20067:00 amRNSCerepro EMEA review
30th Aug 20067:01 amRNSInterim Results
23rd Aug 20067:01 amRNSResearch Update
4th Aug 200612:50 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.